North America Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Laboratory Analyzer [Automated Systems, Semi-Automated Systems, and Manual Systems]), and Point-of-Care Testing Systems), Test (Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, and Others), and End User (Hospitals/ Clinics, Independent Diagnostic Laboratories, Home Care Setting, and Others)
Market Introduction
Hemostasis analyzers are devices that measure clotting mechanisms of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners. Constant technical advancement has led to the launch of many innovative drugs, and instruments such as high-performance hemostasis analyzers are projected to fuel demand growth for hemostasis analyzers.
The report provides trends prevailing in the North America hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.
The North American region is highly affected due to the outbreak of the Covid-19 pandemic. Countries such as the US and Canada reported the highest numbers of COVID-19 positive cases. The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased the demand for diagnosing and therapeutic devices have dramatically increased in the hospitals. For instance, the demand for ventilators, respirators, and in vitro diagnostic (IVD) tests has risen drastically in hospitals across the countries. On the other hand, demand for personal protective kits has significantly gone up. The life sciences segment thrives due to increased demand for in-vitro diagnostic products and rising research and development activities worldwide.
Get more information on this report : 
Market Overview and Dynamics
The North America hemostasis analyzers market in the North America is expected to grow from US$ 1,293.76 million in 2021 to US$ 2,462.45 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028. Cardiovascular diseases have become prevalent across the world, especially in developing nations. The incidences are rising due to the shift in lifestyle and the other health conditions caused by an increased uptake of modernized facilities, which reduced physical activities. The stress level among people has also increased. Healthcare facilities and services in emerging economies are improving and heading toward technological advancements. The opportunities for the market players to enter the market with cost-effective products are higher. Therefore, due to the factors mentioned above, the market's growth is likely to propel in these regions during the forecasted period.
In terms of product type, the laboratory analyzer segment accounted for the largest share of the North America hemostasis analyzers market in 2020. In terms of test, the d-dimer test segment accounted for the largest share of the North America hemostasis analyzers market in 2020. In terms of end user, the hospital/clinics segment accounted for the largest share of the North America hemostasis analyzers market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the North America hemostasis analyzers market in North America are company websites, annual reports, financial reports, national government documents, and statistical databases, among others. Major companies listed in the report are Siemens Healthineers AG, Abbott, Sysmex Corporation, Nihon Kohden Corporation, THERMO FISHER SCIENTIFIC INC., HOFFMANN-LA ROCHE LTD., Instrumentation Laboratory Company, Helena Laboratories Corporation, Diagnostica Stago, Inc., International Technidyne Corporation.
Reasons to buy report
- To understand the North America hemostasis analyzers market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the North America hemostasis analyzers markets.
- Efficiently plan M&A and partnership deals in the North America hemostasis analyzers market by identifying market segments with the most promising probable sales
- Helps to make knowledgeable business decisions from a perceptive and comprehensive analysis of the market performance of various segments for the North America hemostasis analyzers market.
- Obtain market revenue forecast for market by various segments from 2021-2028 in the North America region.
North America Hemostasis Analyzers Market Segmentation
By Product Type
- Laboratory Analyzer
- Automated Systems
- Semi-Automated Systems
- Manual Systems
- Point-of-Care Testing Systems
By Test
- Activated Partial Thromboplastin Time
- D-Dimer Test
- Fibrinogen Test
- Prothrombin Time (PT) Test
- Others
- Hospitals/ Clinics
- Independent Diagnostic Laboratories
- Home Care Setting
- Others
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned -
- Siemens Healthineers AG
- Abbott
- Sysmex Corporation
- Nihon Kohden Corporation
- THERMO FISHER SCIENTIFIC INC.
- HOFFMANN-LA ROCHE LTD.
- Instrumentation Laboratory Company
- Helena Laboratories Corporation
- Diagnostica Stago, Inc
- International Technidyne Corporation
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Hemostasis Analyzers Market– By Product
1.3.2 North America Hemostasis Analyzers Market– By Test
1.3.3 North America Hemostasis Analyzers Market– By End User
1.3.4 North America Hemostasis Analyzers Market– By Country
2. North America Hemostasis Analyzers Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Hemostasis Analyzers Market– Market Landscape
4.1 PEST Analysis
4.1.1 North America – PEST Analysis
4.2 Experts Opinion
5. North America Hemostasis Analyzers Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Cardiovascular Diseases
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Fully Automated Hemostasis Analyzer
5.3 Market Opportunities
5.3.1 Surge in Opportunities in Developing Nations
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact analysis
6. North America Hemostasis Analyzers Market– Country Analysis
6.1 North America Hemostasis Analyzers Market, By Country - Forecast and Analysis
6.2 North America Hemostasis Analyzers Market Revenue Forecast and Analysis
7. North America Hemostasis Analyzers Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 North America Hemostasis Analyzers Market, By Product, 2020 & 2028 (%)
7.2.1 North America: North America Hemostasis Analyzers Market, by Product, 2019–2028 (US$ Million)
7.3 Laboratory Analyzers
7.3.1 Overview
7.3.2 Laboratory Analyzers: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.1 North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
7.3.2.2 Automated Systems
7.3.2.2.1 Overview
7.3.2.2.2 Automated Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.3 Semi-Automated Systems
7.3.2.3.1 Overview
7.3.2.3.2 Semi-Automated Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.4 Manual Systems
7.3.2.4.1 Overview
7.3.2.4.2 Manual Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Point-of-Care Testing Systems
7.4.1 Overview
7.4.2 Point-of-Care Testing Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 – Test
8.1 Overview
8.2 North America Hemostasis Analyzers Market Share by Test - 2020 & 2028 (%)
8.2.1 North America: North America Hemostasis Analyzers Market, by Test, 2019–2028 (US$ Million)
8.3 Activated Partial Thromboplastin Time
8.3.1 Overview
8.3.2 Activated Partial Thromboplastin Time: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
8.4 D-Dimer Test
8.4.1 Overview
8.4.2 D-Dimer Test: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
8.5 Fibrinogen Test
8.5.1 Overview
8.5.2 Fibrinogen Test: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
8.6 Prothrombin Time (PT) Test
8.6.1 Overview
8.6.2 Prothrombin Time Test: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
9. North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 North America Hemostasis Analyzers Market Share by End User - 2020 & 2028 (%)
9.2.1 North America: North America Hemostasis Analyzers Market, by End User, 2019–2028 (US$ Million)
9.3 Hospital/ Clinics
9.3.1 Overview
9.3.2 Hospital/ Clinics: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
9.4 Independent Diagnostic Laboratories
9.4.1 Overview
9.4.2 Independent Diagnostic Laboratories: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Home Care Settings
9.5.1 Overview
9.5.2 Home Care Settings: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
10. North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 – Country Analysis
10.1 North America: North America Hemostasis Analyzers Market
10.1.1 Overview
10.1.2 North America: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1 US: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 US: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 US: North America Hemostasis Analyzers Market, by Product, 2019–2028 (US$ Million)
10.1.2.1.2.1 US North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US: North America Hemostasis Analyzers Market, by Test, 2019–2028 (US$ Million)
10.1.2.1.4 US: North America Hemostasis Analyzers Market, by End User, 2019–2028 (US$ Million)
10.1.2.2 Canada: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Canada: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 Canada: North America Hemostasis Analyzers Market, by Product, 2019–2028 (US$ Million)
10.1.2.2.2.1 Canada North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada: North America Hemostasis Analyzers Market, by Test, 2019–2028 (US$ Million)
10.1.2.2.4 Canada: North America Hemostasis Analyzers Market, by End User, 2019–2028 (US$ Million)
10.1.2.3 Mexico: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Mexico: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 Mexico: North America Hemostasis Analyzers Market, by Product, 2019–2028 (US$ Million)
10.1.2.3.2.1 Mexico North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico: North America Hemostasis Analyzers Market, by Test, 2019–2028 (US$ Million)
10.1.2.3.4 Mexico: North America Hemostasis Analyzers Market, by End User, 2019–2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on North America Hemostasis Analyzers Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. North America Hemostasis Analyzers Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Siemens Healthineers AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Abbott
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sysmex Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Nihon Kohden Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HOFFMANN-LA ROCHE LTD.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Instrumentation Laboratory Company
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Helena Laboratories Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Diagnostica Stago, Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 International Technidyne Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Hemostasis Analyzers Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. North America: North America Hemostasis Analyzers Market, by Test – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Hemostasis Analyzers Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. US North America Hemostasis Analyzers Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. US North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
Table 7. US North America Hemostasis Analyzers Market, by Test – Revenue and Forecast to 2028 (US$ Million)
Table 8. US North America Hemostasis Analyzers Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: North America Hemostasis Analyzers Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: North America Hemostasis Analyzers Market, by Test – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada North America Hemostasis Analyzers Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: North America Hemostasis Analyzers Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico North America Hemostasis Analyzers Market for Laboratory Analyzers, by Product – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: North America Hemostasis Analyzers Market, by Test – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico North America Hemostasis Analyzers Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Hemostasis Analyzers Market Segmentation
Figure 2. North America Hemostasis Analyzers Market Overview
Figure 3. Laboratory Analyzers Held the Largest Share of the Product Segment in North America Hemostasis Analyzers Market
Figure 4. US to Show Significant Growth During Forecast Period
Figure 5. North America PEST Analysis
Figure 6. North America Hemostasis Analyzers Market Impact Analysis of Drivers and Restraints
Figure 7. North America Hemostasis Analyzers Market– By Country Forecast and Analysis – 2021 and 2028
Figure 8. North America Hemostasis Analyzers Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Hemostasis Analyzers Market, by Product, 2020 & 2028 (%)
Figure 10. Laboratory Analyzers: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 11. Automated Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Semi-Automated Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Manual Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Point-of-Care Testing Systems: North America Hemostasis Analyzers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. North America Hemostasis Analyzers Market Share by Test - 2020 & 2028 (%)
Figure 16. Activated Partial Thromboplastin Time: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. D-Dimer Test: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Fibrinogen Test: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Prothrombin Time Test: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Others: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. North America Hemostasis Analyzers Market Share by End User - 2020 & 2028 (%)
Figure 22. Hospital/ Clinics: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Independent Diagnostic Laboratories: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Home Care Settings: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Others: North America Hemostasis Analyzers Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. North America: North America Hemostasis Analyzers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. North America Hemostasis Analyzers Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. US: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Canada: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Mexico: North America Hemostasis Analyzers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Impact of COVID-19 Pandemic in North American Country Markets
Figure 32. Growth Strategies Done by the Companies in the Market, (%)
CONTACT US
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com
DISCLAIMER
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”.
- Siemens Healthineers AG
- Abbott
- Sysmex Corporation
- Nihon Kohden Corporation
- THERMO FISHER SCIENTIFIC INC.
- HOFFMANN-LA ROCHE LTD.
- Instrumentation Laboratory Company
- Helena Laboratories Corporation
- Diagnostica Stago, Inc
- International Technidyne Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hemostasis analyzers market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America hemostasis analyzers market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.